1312163-37-3

Basic information

• Product Name: 4-chloro-N-(2-methoxy-4-morpholinophenyl)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolO[2,3-d]pyrimidin-2-amine
• Synonyms: 4-chloro-N-(2-methoxy-4-morpholinophenyl)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolO[2,3-d]pyrimidin-2-amine
• CAS NO: 1312163-37-3
• Molecular Weight: 481.982
• Mol File: 1312163-37-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-chloro-N-(2-methoxy-4-morpholinophenyl)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolO[2,3-d]pyrimidin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-chloro-N-(2-methoxy-4-morpholinophenyl)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolO[2,3-d]pyrimidin-2-amine(1312163-37-3)
• EPA Substance Registry System: 4-chloro-N-(2-methoxy-4-morpholinophenyl)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolO[2,3-d]pyrimidin-2-amine(1312163-37-3)

Safety Data

• Hazardous Substances Data: 1312163-37-3(Hazardous Substances Data)

Upstream product

• 448-19-1 4-fluoro-2-methoxy-1-nitrobenzene 
• 209960-91-8 2-methoxy-4-morpholinoaniline 
• 1312162-73-4 2,4-dichloro-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine 
• 6950-88-5 4-(3-methoxy-4-nitro-phenyl)morpholine 
• 7459-46-3 triethyl 1,1,2-ethanetricarboxylate 
• 889944-72-3 ethyl 2-(2,4,6-trichloropyrimidin-5-yl)acetate 
• 219312-97-7 2-(2,4,6-trichloropyrimidin-5-yl)ethanol 
• 1312162-74-5 2-(2,4,6-trichloropyrimidin-5-yl)ethyl methanesulfonate 
• 22384-44-7 ethyl 2-(2,4,6-trihydroxypyrimidin-5-yl)acetate 

Downstream Products

• 1312163-38-4 2-(2-(2-methoxy-4-morpholinophenylamino)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-N-methylbenzamide 
• 1312162-29-0 2-(2-(2-methoxy-4-morpholinophenylamino)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-N-methylbenzamide 

Relevant articles and documents

2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS

The invention relates to a novel class of 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as a FAK and/or Pyk2 inhibitor, to a process for their preparation, and to a composition thereof, as well as to use of the compounds for the inhibiting FAK and/or Pyk2 and method for the treatment of a FAK and/ or Pyk2 mediated disorder or disease.